LCI Stock Price Chart More Charts

LCI Price/Volume Stats

Lannett Co Inc (LCI) Company Bio

Lannett Company develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications. The company was founded in 1942 and is based in Philadelphia, Pennsylvania.

LCI Price Forecast Based on DCF Valuation

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Lannett Co Inc. To summarize, we found that Lannett Co Inc ranked in the 92th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. The most interesting components of our discounted cash flow analysis for Lannett Co Inc ended up being:

• 34% of the company's capital comes from equity, which is greater than only 10.86% of stocks in our cash flow based forecasting set.
• The business' balance sheet suggests that 66% of the company's capital is sourced from debt; this is greater than 89.1% of the free cash flow producing stocks we're observing.
• The weighted average cost of capital for the company is 12. This value is greater than 86.16% stocks in the Healthcare sector that generate free cash flow.

SUPN, EGRX, PTN, ARNA, and DPLO can be thought of as valuation peers to LCI, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.